(47) demonstrated that pazopanib resistance in ccRCC results from activation of the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 with acquired pazopanib-resistant of RCC cell line 786-O and xenograft mouse models. Here, STAT3 is linked to renal cell carcinoma.